Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

NCT01241942 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT01241942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01241942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2010
Completion date
March 31, 2013
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alpha-1 antitrypsin deficiency, bronchiectasis, chronic obstructive pulmonary disease (copd), cystic fibrosis, emphysema, pulmonary fibrosis, pulmonary hypertension, sarcoidosis